Jonathan Yon
Stock Analyst at Credit Suisse
(2.08)
# 2,975
Out of 5,156 analysts
16
Total ratings
54.55%
Success rate
4.87%
Average return
Main Sectors:
Stocks Rated by Jonathan Yon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Maintains: Outperform | $163 → $169 | $190.53 | -11.30% | 3 | Jul 27, 2023 | |
| PRVA Privia Health Group | Reiterates: Outperform | $41 | $23.30 | +75.97% | 2 | Jun 22, 2023 | |
| CYH Community Health Systems | Maintains: Neutral | $8.5 → $7.4 | $3.51 | +110.83% | 1 | May 3, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $31 → $32 | $10.06 | +218.09% | 1 | Feb 23, 2023 | |
| SLQT SelectQuote | Maintains: Neutral | $1 → $3 | $0.76 | +295.99% | 1 | Feb 22, 2023 | |
| MD Pediatrix Medical Group | Maintains: Outperform | $27 → $23 | $20.10 | +14.43% | 3 | Feb 22, 2023 | |
| HCA HCA Healthcare | Maintains: Outperform | $296 → $260 | $545.13 | -52.30% | 1 | Apr 25, 2022 | |
| CLOV Clover Health Investments | Downgrades: Underperform | $9 → $3.5 | $2.00 | +75.00% | 2 | Jan 7, 2022 | |
| CI The Cigna Group | Maintains: Outperform | $270 → $300 | $269.66 | +11.25% | 1 | Nov 8, 2021 | |
| CNC Centene | Maintains: Neutral | $74 → $70 | $43.32 | +61.59% | 1 | Sep 14, 2021 |
Universal Health Services
Jul 27, 2023
Maintains: Outperform
Price Target: $163 → $169
Current: $190.53
Upside: -11.30%
Privia Health Group
Jun 22, 2023
Reiterates: Outperform
Price Target: $41
Current: $23.30
Upside: +75.97%
Community Health Systems
May 3, 2023
Maintains: Neutral
Price Target: $8.5 → $7.4
Current: $3.51
Upside: +110.83%
Cross Country Healthcare
Feb 23, 2023
Maintains: Neutral
Price Target: $31 → $32
Current: $10.06
Upside: +218.09%
SelectQuote
Feb 22, 2023
Maintains: Neutral
Price Target: $1 → $3
Current: $0.76
Upside: +295.99%
Pediatrix Medical Group
Feb 22, 2023
Maintains: Outperform
Price Target: $27 → $23
Current: $20.10
Upside: +14.43%
HCA Healthcare
Apr 25, 2022
Maintains: Outperform
Price Target: $296 → $260
Current: $545.13
Upside: -52.30%
Clover Health Investments
Jan 7, 2022
Downgrades: Underperform
Price Target: $9 → $3.5
Current: $2.00
Upside: +75.00%
The Cigna Group
Nov 8, 2021
Maintains: Outperform
Price Target: $270 → $300
Current: $269.66
Upside: +11.25%
Centene
Sep 14, 2021
Maintains: Neutral
Price Target: $74 → $70
Current: $43.32
Upside: +61.59%